Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

NanoSpectra Biosciences
8285 El Rio St #150
Houston, TX 77054
Phone: 713-842-2720
http://www.nanospectra.com/

Nanospectra Biosciences is a privately-held medical device company, pioneering the patient-centric use of nanomedicine for selective thermal ablation. AuroLase, the company's lead product, is the first ultra-focal therapy for prostate cancer. Nanospectra's ultra-focal approach maximizes treatment efficacy while minimizing side effects associated with current treatments, including surgery, radiation, and alternative focal therapies. Implementing a multi-prong growth strategy, Nanospectra is focusing on clinical advancements, exclusive partnering agreements and ongoing research and development. Nanospectra's technology development has been funded to date by a series of grants, private equity investments and corporate partnerships.

Key Contact
Name
David Jorden
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
09/08/20 $3,000,000 Series B-1 Sirtex Medical
undisclosed